Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Primary Tumour Surgery in Oligometastatic Breast Cancer for Improving Overall Survival: A Quasi-Experimental Study

NCT07586319 is registered in ClinicalTrials.gov with Sharif Medical Research Center as lead sponsor.

NCT NCT07586319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07586319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Primary Tumour Surgery in Oligometastatic Breast Cancer for Improving Overall Survival: A Quasi-Experimental Study
Lead sponsor
Sharif Medical Research Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
June 1, 2026
Completion date
June 1, 2031
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

survival outcomes